Skip to content
Medical Health Aged Care

Delay giving NSW GPs information on imminent payroll tax changes not good enough

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) says New South Wales GPs have not been given enough time to prepare for payroll tax changes with no information just seven business days from when the changes take effect. 

RACGP NSW Chair Dr Rebekah Hoffman said: “It’s incredibly disappointing that we are just seven business days from when these significant changes take effect, and GPs still have no information from Revenue NSW. 

“This is nowhere near enough time for GPs to prepare and make changes that they may need, and it’s causing a great deal of unnecessary stress for GPs when we just want to get on with caring for our patients. It’s not good enough. 

“We appreciate that the NSW Government granted no retrospectivity for payroll tax on independent GPs, as this will help ensure practices aren’t sent bankrupt and can keep their doors open for patients. 

“However, practices may need to make changes in line with the new rules, and this will take time. The RACGP requested an extension to the amnesty to allow the time needed for GPs to adapt, but it was declined.  

“Now NSW GPs are stuck in a very difficult situation, knowing these changes are coming, but not knowing what they need to do to prepare. Again, I urge the NSW Government to provide an extension to the amnesty, so GPs have time to make the changes they need to, and patient care is not disrupted.” 

General practices have always paid payroll tax on their employees, including receptionists, GPs in training and nurses, but it never applied to GPs because most are not employees, they work under independent agreements. This changed after a final ruling by the NSW Court of Appeal in 2023 deemed independent practitioners as employees for payroll tax purposes. 

In June this year, the NSW Government agreed to no retrospective tax, and an exemption tied to general practices meeting bulk billing thresholds, after strong warnings from the RACGP that this would result in widespread practice bankruptcies and closures. 

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992media@racgp.org.au

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 15/01/2025
  • 20:54
Glaxo SmithKline

Local scientific discovery Omjarra (momelotinib) TGA approved for Australians with rare bone marrow cancer

MELBOURNE PHOTO-FILMING OPPORTUNITY: THURSDAY 16TH JANUARY 2025 DATE: Thursday 16th January 2025 TIME: 10.30 – 11.30am LOCATION: 3 Torresdale Road, Toorak, Melbourne INTERVIEWEES: Prof…

  • Contains:
  • Medical Health Aged Care
  • 15/01/2025
  • 10:33
Monash University

The Lancet Diabetes & Endocrinology: Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease.

A global Commission, published in The Lancet Diabetes & Endocrinology and endorsed by 75 medical organisations around the world [1], presents a novel, nuanced approach to diagnose obesity, based on other measures of excess body fat in addition to body mass index (BMI), and objective signs and symptoms of ill health at the individual level. The proposal is designed to address limitations in the traditional definition and diagnosis of obesity that hinder clinical practice and healthcare policies, resulting in individuals with obesity not receiving the care they need. By providing a medically coherent framework for disease diagnosis, the Commission also…

  • Medical Health Aged Care
  • 14/01/2025
  • 17:10
Galderma

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra® and Restylane® Lyft™ or Contour™ effectively improved the facial aesthetic appearance of…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.